Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.28 EUR | -2.28% | -1.91% | -9.90% |
May. 08 | Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Laboratory chain Synlab starts the year with lower revenue | DP |
Business Summary
Number of employees: 23,538
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Medicine
97.6
%
| 3,168 | 97.5 % | 2,572 | 97.6 % | -18.79% |
Veterinary Medicine
1.1
%
| 42 | 1.3 % | 29 | 1.1 % | -29.98% |
Trading Goods and Services
0.7
%
| 20 | 0.6 % | 20 | 0.7 % | -1.03% |
Environmental and Other Analysis, Studies, Expertise
0.3
%
| 10 | 0.3 % | 9 | 0.3 % | -10.26% |
Software Solutions and Services
0.2
%
| 12 | 0.4 % | 6 | 0.2 % | -53.57% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
20.3
%
| 703 | 21.6 % | 536 | 20.3 % | -23.75% |
France
19.9
%
| 674 | 20.7 % | 524 | 19.9 % | -22.24% |
South
17.5
%
| 0 | 0.0 % | 461 | 17.5 % | - |
Italy
13.0
%
| 355 | 10.9 % | 343 | 13.0 % | -3.59% |
United Kingdom
13.0
%
| - | - | 343 | 13.0 % | - |
North & East
8.3
%
| 913 | 28.1 % | 217 | 8.3 % | -76.17% |
Latin America
8.0
%
| 192 | 5.9 % | 211 | 8.0 % | +9.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 56 | 21-01-25 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 21-01-25 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 41 | - | |
Chief Tech/Sci/R&D Officer | - | - | |
Mark Reinhard
IRC | Investor Relations Contact | - | 20-12-31 |
Walla Fabian
SEC | Corporate Secretary | - | - |
Human Resources Officer | - | - | |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 21-01-10 |
Founder | 63 | 97-12-31 | |
Marc Welters
BRD | Director/Board Member | - | 21-04-28 |
Director/Board Member | 50 | 21-04-28 | |
Barbara Lambert
BRD | Director/Board Member | 62 | 21-01-10 |
Karin Bierstedt
BRD | Director/Board Member | 52 | 21-04-28 |
Stefan Graf
BRD | Director/Board Member | 65 | 21-04-28 |
Ute Hasholzner
BRD | Director/Board Member | 65 | 21-04-28 |
Director/Board Member | 62 | 21-04-28 | |
Iris Schopper
BRD | Director/Board Member | 36 | 21-04-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 222,222,222 | 31,594,456 ( 14.22 %) | 2,447,000 ( 1.101 %) | 14.22 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SYNLAB AG 1.10% | 2,447,000 | 1.10% | 27,472,763 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
SYNLAB Bondco Plc
SYNLAB Bondco Plc Financial ConglomeratesFinance SYNLAB Bondco Plc offers medical diagnostics for patients, practicing doctors, clinics and the pharmaceutical industry. The company was founded on March 23, 2015 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.80% | 8.49B | |
+58.90% | 4.08B | |
-39.78% | 2.42B | |
-3.13% | 2.33B | |
-2.53% | 2.01B | |
-19.90% | 1.53B | |
-38.30% | 1.26B | |
+2.19% | 1.07B | |
+14.82% | 985M |
- Stock Market
- Equities
- SYAB Stock
- SYAB Stock
- Company SYNLAB AG